| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | - | - | - | - | - | - | 0 |
| Total Income - EUR | 0 | 0 | 0 | - | - | - | - | - | - | 0 |
| Total Expenses - EUR | 144 | 2.044 | 4.709 | - | - | - | - | - | - | 24 |
| Gross Profit/Loss - EUR | -144 | -2.044 | -4.709 | - | - | - | - | - | - | -24 |
| Net Profit/Loss - EUR | -144 | -2.044 | -4.709 | - | - | - | - | - | - | -24 |
| Employees | 0 | 0 | 0 | - | - | - | - | - | - | 0 |
Check the financial reports for the company - Belladonna Pharmakon Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 26 | 0 | 0 | - | - | - | - | - | - | 0 |
| Current Assets | 42 | 127 | 121 | - | - | - | - | - | - | 827 |
| Inventories | 0 | 0 | 0 | - | - | - | - | - | - | 0 |
| Receivables | 0 | 0 | 0 | - | - | - | - | - | - | 804 |
| Cash | 42 | 127 | 121 | - | - | - | - | - | - | 23 |
| Shareholders Funds | -99 | -2.142 | -6.816 | - | - | - | - | - | - | -7.229 |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | 40 |
| Debts | 168 | 2.269 | 6.936 | - | - | - | - | - | - | 8.056 |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Belladonna Pharmakon Srl